342 related articles for article (PubMed ID: 18068992)
1. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
Kimber TE; Thompson PD; Kiley MA
J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
[TBL] [Abstract][Full Text] [Related]
2. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
3. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
Voon V; Potenza MN; Thomsen T
Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
[TBL] [Abstract][Full Text] [Related]
4. Impulsive and compulsive behaviors in Parkinson's disease.
Evans AH; Strafella AP; Weintraub D; Stacy M
Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
[TBL] [Abstract][Full Text] [Related]
6. Compulsive eating and weight gain related to dopamine agonist use.
Nirenberg MJ; Waters C
Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
[TBL] [Abstract][Full Text] [Related]
7. Compulsive singing: another aspect of punding in Parkinson's disease.
Bonvin C; Horvath J; Christe B; Landis T; Burkhard PR
Ann Neurol; 2007 Nov; 62(5):525-8. PubMed ID: 17696122
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
[TBL] [Abstract][Full Text] [Related]
9. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic dysregulation syndrome in Parkinson's disease.
Katzenschlager R
J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
13. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
14. Dopamine agonist withdrawal syndrome in Parkinson disease.
Rabinak CA; Nirenberg MJ
Arch Neurol; 2010 Jan; 67(1):58-63. PubMed ID: 20065130
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced impulse control disorders in Parkinson's disease.
Reiff J; Jost WH
J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
[TBL] [Abstract][Full Text] [Related]
16. Alteration of eating behaviors in patients with Parkinson's disease: possibly overlooked?
Miwa H; Kondo T
Neurocase; 2008; 14(6):480-4. PubMed ID: 19012168
[TBL] [Abstract][Full Text] [Related]
17. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
[TBL] [Abstract][Full Text] [Related]
18. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
Ahlskog JE
Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
[TBL] [Abstract][Full Text] [Related]
19. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
McKeon A; Josephs KA; Klos KJ; Hecksel K; Bower JH; Michael Bostwick J; Eric Ahlskog J
Parkinsonism Relat Disord; 2007 Dec; 13(8):516-9. PubMed ID: 17544807
[TBL] [Abstract][Full Text] [Related]
20. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
Zand R
Eur Neurol; 2008; 59(3-4):183-6. PubMed ID: 18230877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
